Reappraising the relationship between hyperinsulinemia and insulin resistance in PCOS
Journal of Endocrinology · 01.05.2025 · 265 (2)
DOI: 10.1530/joe-24-0269 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Endocrinology, online erschienen am 27.02.2025. Verfasst von Emma J Houston und 1 weiteren Autor:innen. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Insulin Resistance, Hyperinsulinism. Die Arbeit wurde bisher 81-mal zitiert (Crossref) und nennt 179 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Canadian Institutes of Health Research, Natural Sciences and Engineering Research Council of Canada.
Abstract (Originalsprache)
Polycystic ovary syndrome (PCOS), a reproductive endocrine disorder with quintessential features of metabolic dysfunction, affects millions of women worldwide. Hyperinsulinemia (i.e., elevated insulin without hypoglycemia) is a common metabolic feature of PCOS that worsens its reproductive symptoms by exacerbating pituitary hormone imbalances and increasing levels of bioactive androgens. Hyperinsulinemia in PCOS is often attributed to insulin resistance, based on the concept that impaired insulin-mediated glucose disposal would induce compensatory insulin hypersecretion. However, it is challenging to define the sequential relationship between insulin sensitivity and insulin secretion, as they are tightly interlinked, and evidence suggests that hyperinsulinemia can alternatively precede insulin resistance. Notably, other drivers of hyperinsulinemia (outside of insulin resistance) may be highly relevant in the context of PCOS. For instance, high androgen levels can augment both hyperinsulinemia and insulin resistance, generating a self-perpetuating cycle of reproductive and metabolic dysfunction. In this review, we evaluate the cause-and-effect relationships between insulin resistance and hyperinsulinemia in PCOS. We examine evidence for the prevailing theory of insulin resistance as the primary defect that causes secondary compensatory hyperinsulinemia, and an alternative framework of hyperinsulinemia as the earlier defect that perpetuates reproductive and metabolic features of PCOS. Considering the heterogeneous nature of PCOS, it is improbable that its metabolic characteristics always follow the same progression. Comprehensively examining all mechanistic regulators of hyperinsulinemia and insulin resistance in PCOS might thereby lead to improved prevention and management strategies, and address critical knowledge gaps in the progression of PCOS pathogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
ORCID-Profile: Nicole M Templeman
Förderung
- Canadian Institutes of Health Research
- Natural Sciences and Engineering Research Council of Canada
Zitieren
APA
Houston, E. J., & Templeman, N. M. (2025). Reappraising the relationship between hyperinsulinemia and insulin resistance in PCOS. Journal of Endocrinology, 265(2). https://doi.org/10.1530/joe-24-0269
Vancouver
Houston EJ, Templeman NM. Reappraising the relationship between hyperinsulinemia and insulin resistance in PCOS. Journal of Endocrinology. 2025;265(2). doi:10.1530/joe-24-0269
BibTeX
@article{Houston2025,
author = {Houston, Emma J and Templeman, Nicole M},
title = {Reappraising the relationship between hyperinsulinemia and insulin resistance in PCOS},
journal = {Journal of Endocrinology},
year = {2025},
volume = {265},
number = {2},
doi = {10.1530/joe-24-0269}
}
EUVIMED